BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 25753847)

  • 1. Longitudinal brain volumetric changes and their predictive effects on cognition among cognitively asymptomatic patients with Parkinson's disease.
    Wen MC; Ng A; Chander RJ; Au WL; Tan LC; Kandiah N
    Parkinsonism Relat Disord; 2015 May; 21(5):483-8. PubMed ID: 25753847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
    Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
    Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease.
    Ong M; Foo H; Chander RJ; Wen MC; Au WL; Sitoh YY; Tan L; Kandiah N
    J Neurol Sci; 2017 Jun; 377():122-126. PubMed ID: 28477681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease.
    Lee JE; Cho KH; Song SK; Kim HJ; Lee HS; Sohn YH; Lee PH
    J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):7-16. PubMed ID: 23828835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment.
    Noh SW; Han YH; Mun CW; Chung EJ; Kim EG; Ji KH; Seo JH; Kim SJ
    J Neurol Sci; 2014 Dec; 347(1-2):210-3. PubMed ID: 25451006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anatomical substrates and neurocognitive predictors of daily numerical abilities in mild cognitive impairment.
    Benavides-Varela S; Burgio F; Meneghello F; De Marco M; Arcara G; Rigon J; Pilosio C; Butterworth B; Venneri A; Semenza C
    Cortex; 2015 Oct; 71():58-67. PubMed ID: 26159324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gray matter atrophy associated with mild cognitive impairment in Parkinson's disease.
    Chen FX; Kang DZ; Chen FY; Liu Y; Wu G; Li X; Yu LH; Lin YX; Lin ZY
    Neurosci Lett; 2016 Mar; 617():160-5. PubMed ID: 26742642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive brain atrophy in Parkinson's disease patients who convert to mild cognitive impairment.
    Zhou C; Guan XJ; Guo T; Zeng QL; Gao T; Huang PY; Xuan M; Gu QQ; Xu XJ; Zhang MM
    CNS Neurosci Ther; 2020 Jan; 26(1):117-125. PubMed ID: 31278861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Following the Spreading of Brain Structural Changes in Alzheimer's Disease: A Longitudinal, Multimodal MRI Study.
    Weiler M; Agosta F; Canu E; Copetti M; Magnani G; Marcone A; Pagani E; Balthazar ML; Comi G; Falini A; Filippi M
    J Alzheimers Dis; 2015; 47(4):995-1007. PubMed ID: 26401778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in white matter integrity before conversion from mild cognitive impairment to Alzheimer's disease.
    Defrancesco M; Egger K; Marksteiner J; Esterhammer R; Hinterhuber H; Deisenhammer EA; Schocke M
    PLoS One; 2014; 9(8):e106062. PubMed ID: 25153085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of white matter lesions (WML) to Parkinson's disease cognitive impairment symptoms: A critical review of the literature.
    Veselý B; Rektor I
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S166-70. PubMed ID: 26391185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White matter hyperintensities are not associated with cognitive decline in early Parkinson's disease - The DeNoPa cohort.
    Hanning U; Teuber A; Lang E; Trenkwalder C; Mollenhauer B; Minnerup H
    Parkinsonism Relat Disord; 2019 Dec; 69():61-67. PubMed ID: 31678722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of subcortical atrophy in mild Parkinson's disease and its impact on cognition.
    Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Sitoh YY; Tan LC; Kandiah N
    Eur J Neurol; 2017 Feb; 24(2):341-348. PubMed ID: 27943468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild cognitive impairment in Parkinson's disease is associated with a distributed pattern of brain white matter damage.
    Agosta F; Canu E; Stefanova E; Sarro L; Tomić A; Špica V; Comi G; Kostić VS; Filippi M
    Hum Brain Mapp; 2014 May; 35(5):1921-9. PubMed ID: 23843285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voxel-based meta-analysis of gray matter volume reductions associated with cognitive impairment in Parkinson's disease.
    Xu Y; Yang J; Hu X; Shang H
    J Neurol; 2016 Jun; 263(6):1178-87. PubMed ID: 27113603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White matter alterations in Parkinson's disease with normal cognition precede grey matter atrophy.
    Rektor I; Svátková A; Vojtíšek L; Zikmundová I; Vaníček J; Király A; Szabó N
    PLoS One; 2018; 13(1):e0187939. PubMed ID: 29304183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease with mild cognitive impairment: severe cortical thinning antedates dementia.
    Gasca-Salas C; García-Lorenzo D; Garcia-Garcia D; Clavero P; Obeso JA; Lehericy S; Rodríguez-Oroz MC
    Brain Imaging Behav; 2019 Feb; 13(1):180-188. PubMed ID: 28710667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study.
    Chételat G; Landeau B; Eustache F; Mézenge F; Viader F; de la Sayette V; Desgranges B; Baron JC
    Neuroimage; 2005 Oct; 27(4):934-46. PubMed ID: 15979341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A diffusion tensor MRI study of patients with MCI and AD with a 2-year clinical follow-up.
    Scola E; Bozzali M; Agosta F; Magnani G; Franceschi M; Sormani MP; Cercignani M; Pagani E; Falautano M; Filippi M; Falini A
    J Neurol Neurosurg Psychiatry; 2010 Jul; 81(7):798-805. PubMed ID: 20392973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.